NEWS & INSIGHTS

The network

Exceptional cancer survival can be found anywhere in the world. Follow our international network of leading oncology centers, clinicians and researchers coming together across countries to identify these rare survivors and help uncover what makes their survival possible.

International oncology network | Rosalind Study

Happy 14 Juillet! French oncology centers are an important part of our oncology network

Liberté, Égalité, Fraternité… and a shared commitment to advance cancer research

Jul 14, 2026

New strategic partnerships: our global oncology network continues to expand!

Together, we're building the world's most comprehensive database of exceptional cancer survivors

May 25, 2026

CHUV-Centre-hospitalier-universitaire-vaudois

CHUV Lausanne received their Rosalind trophy!

Our partnership with CHUV plays a critical role in advancing our Rosalind Study

May 11, 2026

cure51-servier-paris-saclay-pscc-annual-event

Sharing Insights: our CEO Nicolas Wolikow Speaks at PSCC Annual Event!

Biotech startups and pharmaceutical companies can strengthen partnerships to accelerate drug development

Apr 7, 2026

How Cure51 Builds a Global Cancer Research Project Across 50+ Countries

Running an international oncology network across 50+ countries requires rigorous coordination and strict clinical research compliance

Mar 25, 2026

A Strategic Partnership to Rethink Pancreatic Cancer Treatment: Cure51 × CRCM × Institut Paoli-Calmettes

Mar 10, 2026

Rosalind-Study-worldwide-oncology-network

Celebrating a huge Rosalind Study milestone: 115+ worldwide partner oncology centers!

Rosalind Study Milestone: 115+ Centers Join Cure51’s International Oncology Network

Feb 17, 2026

Simon-Istolainen-Nicolas-Wolikow-Cure51-Exceptional-Cancer-Survivors

Happy New Year 2026! Reflecting on Cure51’s Cancer Research Progress & the Rosalind Study

Jan 2, 2026

Rosalind Study Launches in Dubai to Advance Cancer Research

Rosalind Study Launches in Dubai in collaboration with Mediclinic Middle East City Hospital and Dr. Shaheenah Dawood to Advance Cancer Research

Dec 23, 2025

ROSALIND